DISCLOSURE OF CONFLICTS OF INTEREST
AASLD requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosures are collected prior to the start of the educational activity. Any potential conflicts of interest that exist are resolved prior to implementation of the activity. All disclosures are made available and communicated to the leaner prior the activity beginning.
The organizers and faculty have reported the following disclosures:
Faculty
Jesus Banales, PhD
Nothing to disclose.
Nabeel M. Bardeesy, PhD
Nothing to disclose.
Mitesh Borad, MD
Nothing to disclose.
Umberto Cillo, MD
Nothing to disclose.
Laura Dawson, MD, FRCPC
Nothing to disclose.
Luca Fabris, MD, PhD
Nothing to disclose.
Gregory J. Gores, MD, FAASLD
Scientific Consulting: Co-editor of Seminars in Liver Disease
Tim Greten, MD
Nothing to disclose.
Julie Heimbach, MD, FAASLD
Advisory Committees and/or Review Panels: ASTS Council
Kimberly JoHong, MD
Nothing to disclose.
Jill Koshiol, PhD
Nothing to disclose.
Stacie Lindsey
Nothing to disclose.
Jospe M. Llovet, MD, FAASLD
Scientific Consulting: Can-Fite Biopharma, Eli Lilly, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb, Eisai Inc, Celsion Corporation, Exelixis, Merck, Ipsen, Genentech, Roche, Glycotest, Leerink Swann LLC, Fortress Biotech, Nucleix, Sirtex, Mina Alpha Ltd, AstraZeneca
Grants/Research Support: Bayer HealthCare Pharmaceuticals, Eisai Inc, Bristol-Myers Squibb, Boehringer-Ingelheim and Ipsen
David C. Madoff, MD
Nothing to disclose.
Shishri K. Maithel, MD
Grants/Research Support: Celgene
Valerie Paradis, MD, PhD
Nothing to disclose.
Tushar Patel, MBCbB, FAASLD
Nothing to disclose.
Sumera H. Rizvi, MD
Nothing to disclose.
Florin M. Selaru, MD
Nothing to disclose.
Daniela Sia, PhD
Nothing to disclose.
Mario Strazzabosco, MD, PhD, FAASLD
Scientific Consulting: Bayer, Engitix
Andrew X. Zhu, MD, PhD
Scientific Consulting: Bayer, Merck, Lilly, Novartis, Eisai, Roche-Genentech, Exelixis
Basic Research Committee
Muyiwa Awoniyi, MD, PhD
Nothing to disclose
Lily Dara, MD
Nothing to disclose
Laurie D. DeLeve, MD, PhD, FAASLD
Intellectual Property Rights (Patents, Royalties, Licensing fees): COMPOSITIONS AND METHODS FOR AMELIORATING TISSUE INJURY, ENHANCING LIVER REGENERATION AND STEM CELL THERAPIES, 2017-230-01 US no. 62/544,589 End-organ selective MMP inhibition enhances bone marrow progenitor cell recruitment (sole inventor) Applicant: University of Southern California GBC ref.: 6177.132445PCT
Scientific Consultant/Advisor to Industry or Commercial Enterprise: Abbvie; Daiichi Sankyo
Ariel E. Feldstein, MD
Scientific Consultant/Advisor to Industry or Commercial Enterprise: Gilead, Merck, Oppilan Pharma, GSK
Sandy Feng, MD, PhD
Stock/Stock Options: Amgen, Johnson & Johnson, Stryker, Abbott, Charles River Labs, Eli Lily, Express Scripts, Glaxo-Smith Klein, Medco, Merck, Pfizer, Hospira
Grants/Research Support: Novartis, Quark
Leadership in related society: Juno Therapeutics, Inc., American Journal of Transplantation, Immune Tolderance Network, OPTN/UNOS, The New England Journal of Medicine
Mercedes Fernandez, PhD
Nothing to disclose
Rohit Kohli, MBBS, MS, FAASLD
Commercial Speaker's Bureau: Alexion Pharmaceuticals
Data Safety Monitoring Board for Industry or Commercial Enterprise: Takeda Pharmacrutical
Grants/Research Support: Epigen Pharma, Vision Pharmaceuticals
Leadership in related society: NASPGHAN Foundation Board
T. Jake Liang, MD, FAASLD
Nothing to disclose
Pranoti Mandrekar, PhD, FAASLD
Nothing to disclose
Kaitlyn R. Musto, PA-C
Nothing to disclose
Laura E. Nagy, PhD, FAASLD
Nothing to disclose
Kari Nejak-Bowen, MBA, PhD
Nothing to disclose
Ruisi Wang, PhD
Nothing to disclose
Huiping Zhou, PhD, FAASLD
Nothing to disclose
Clinical Research Committee
Ulrich Beuers, MD
Scientific Consultant/Advisor to Industry or Commercial Enterprise, including Development of Educational Presentations: Valeant, Norgine
Grants/Research Support: Valeant, Grifols
Leadership in related society: ACG: American Journal of Gastroenterology AE, AGA: Microbiome Scientific Advisory Board;
Jasmohan S. Bajaj, MD, FAASLD
Grants/Research Support: Lallemand Pharma; Commercial Speaker's Bureau: Lupin Pharma
Mamatha Bhat, MD
Nothing to disclose
Therese Bittermann, MD
Nothing to disclose
Edward Doo, MD
Grants/Research Support: Abbvie, BMS, Gilead
Scientific Consultant/Advisor to Industry or Commercial Enterprise: Abbvie, Gilead
W. Ray Kim, MD, FAASLD
Advisory Board: Merck, Gilead Science, Abbvie, Salix
Scientific Consultant/Advisor to Industry or Commercial Enterprise: Connatus
Paul Yien Kwo, MD, FAASLD
Grants/Research Support: Allergan, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, Galectin Therapeutics, Galmed Pharmaceuticals, GE, Genfit, Gilead, Intercept, Janssen, Madrigal Pharmaceuticals, Merck, NGM Biopharmaceuticals, Pfizer, and Siemens
Scientific Consultant/Advisor to Industry or Commercial Enterprise: Glympse bio, Metacrine, Viking, Ini Pharma Ionis, Intercept, Ionis, Janssen Inc., Merck, NGM Biopharmaceuticals, Novo Nordisk, Pfizer,Madrigagal
Rohit Loomba, MD
Nothing to disclose
Arpan Arun Patel, MD
Grants/Research Support: Gilead, Shire
Emily J. Rothbaum Perito, MD
Nothing to disclose
Susan M. Salahshor, PhD, PA-C
Grants/Research Support: Organ Recovery Systems
Shimul A. Shah, MD
Nothing to disclose
Tracey G. Simon, MD
Nothing to disclose
James E. Squires, MD, MS
Nothing to disclose
Monica A. Tincopa, MD MSc
Nothing to disclose
Kymberly Watt, MD
Expert Testimony: Intercept - site- PI Gilead - site PI, co-I Conatus - site co-I Novartis - previous site PI, co author study subanalysis Pfizer- site co-I all multicenter study related
Stock/Stock Options: BMS; Arbutus; Madrigal; Viking
AASLD Staff
Dominique Clayton
Nothing to disclose
Julie Deal
Nothing to disclose
Matthew D’Uva
Nothing to disclose
Denise Seise
Nothing to disclose
Suzanne Thibeault
Nothing to disclose
Anne Wrobel
Nothing to disclose